All Options USA’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-29
Closed -$330 – 1376
2026
Q1
$330 Buy
+29
New +$314 ﹤0.01% 1139

Other funds holding ANGO

All Options USA's ANGO Position: Q2 2026 in Review

All Options USA sold out of AngioDynamics (ANGO) in Q2 2026, closing a stake of 29 shares — an estimated $330 sold.

All Options USA first reported a position in ANGO in Q1 2026 and held it in 1 quarter. The position peaked at $330 in Q1 2026. 163 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • All Options USA reported no remaining AngioDynamics position as of Q2 2026 after selling out during the quarter.
  • All Options USA sold 29 AngioDynamics shares in Q2 2026, an estimated $330.
  • All Options USA first reported a position in AngioDynamics in Q1 2026 and held it in 1 quarter.
  • All Options USA's AngioDynamics position peaked at $330 in Q1 2026.
  • 163 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on All Options USA's 13F filing for Q2 2026, filed 12 Nov 2026.